Next Article in Journal
Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance
Next Article in Special Issue
Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?
Previous Article in Journal
Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp.
Previous Article in Special Issue
IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic Leukemia
 
 
Systematic Review

Article Versions Notes

Cancers 2021, 13(7), 1649; https://doi.org/10.3390/cancers13071649
Action Date Notes Link
article xml file uploaded 1 April 2021 11:27 CEST Original file -
article xml uploaded. 1 April 2021 11:27 CEST Update https://www.mdpi.com/2072-6694/13/7/1649/xml
article pdf uploaded. 1 April 2021 11:27 CEST Version of Record https://www.mdpi.com/2072-6694/13/7/1649/pdf
article supplementary file uploaded. 1 April 2021 11:27 CEST - https://www.mdpi.com/2072-6694/13/7/1649#supplementary
article html file updated 1 April 2021 11:28 CEST Original file -
article html file updated 1 April 2021 13:31 CEST Update -
article html file updated 10 April 2021 21:41 CEST Update -
article html file updated 3 August 2021 23:00 CEST Update -
article html file updated 3 August 2021 23:18 CEST Update -
article html file updated 25 July 2022 10:19 CEST Update https://www.mdpi.com/2072-6694/13/7/1649/html
Back to TopTop